CG Oncology (CGON) EV to CFO (2024 - 2026)
Powered by 
Analysis
CG Oncology (CGON) EV to CFO (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.87 Bn | 132.01 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.74 Bn | 77.75 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.52 Bn | 58.34 Bn | 1.37 Bn |
| 4 | Moderna | 57.30 Bn | 52.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.00 Bn | 44.00 Bn | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.18 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.57 Bn | 27.73 Bn | - |
| 9 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn |
| 10 | CG Oncology | 6.53 Bn | 6.53 Bn | -2.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -112.92 |
| Mar 31, 2026 | -85.70 |
| Dec 31, 2025 | -72.01 |
| Sep 30, 2025 | -63.58 |
| Jun 30, 2025 | -47.25 |
| Mar 31, 2025 | -40.24 |
| Dec 31, 2024 | -50.84 |
| Sep 30, 2024 | -126.11 |
| Jun 30, 2024 | -96.25 |
| Mar 31, 2024 | -57.65 |